Categories Article Boron Compounds Chemistry In-vitro Studies In-vivo Studies Radiobiology Year 2020 Sunitinib containing carborane pharmacophore with ability to inhibit tyrosine kinases receptors, FLT3, KIT, and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity Post author By ISNCT Post date September 27, 2022 Cancers, 2020 Tags B. Dávila, C. Alamón, C. Sánche, C. Viñas, Cancers, E. Trias, F. Teixidor, L. Barbeito, M. Couto and H. Cerecetto, M. Gabay, M. Gavish, M. Kovacs, M.F. García, N. Zeineh
Categories Article Boron Compounds Boron Determination Chemistry In-vitro Studies Radiobiology Year 2020 Closo-carboranyl- and Metallacarboranyl[1,2,3]-triazolyl-decorated Lapatinib-scaffold for Cancer Therapy Combining Tyrosine Kinase Inhibition and Boron Neutron Capture Therapy Post author By ISNCT Post date September 27, 2022 Cells, 2020 Tags C. Alamón, C. Viñas and H. Cerecetto, Cells, E. Pozzi, E. Trias, F. Teixidor, M. Couto, M. Kovacs, M.A. Dagrosa, M.F. García, P. Curotto, S. Nievas, S. Thorp
Categories Article Boron Compounds Chemistry In-vitro Studies Radiobiology Year 2020 Bimodal Therapeutic Agent against Glioblastoma, one the most Lethal Cancer Post author By ISNCT Post date September 27, 2022 Chemistry European Journal, 2020 Tags C. Alamón, C. Viñas and H. Cerecetto, Chemistry European Journal, F. Teixidor, M. Couto, M. Perona, M.A. Dagrosa, P. Cabral, S. Nievas
ISNCTISNCT